Global Patient-derived Xenograft (PDX) Models market cagr 12.8%

Page 1


Patient-derived Xenograft (PDX) Models

Market

Patient-derived Xenograft (PDX) Models Market

Scope: Industry Analysis, Market Size, Growth, Trends Till 2031

Request Sample Report

Patient-derived Xenograft (PDX) Models Market Size and Growth

The Patient-derived Xenograft (PDX) Models market is experiencing significant growth, driven by advancements in personalized medicine. As of 2023, the market is valued at approximately $300 million, with increasing demand for effective cancer therapies. Key trends include enhanced model development and expanding applications in drug discovery and development. Request Sample Report

Companies Covered

(Covid 19 Impact Covered)

◍ Crown Bioscience

◍ Champions Oncology

◍ Wuxi Apptec

◍ The Jackson Laboratory

◍ EPO Berlin-Buch

◍ Oncodesign

◍ Xentech

◍ Envigo

◍ Charles River Laboratories

◍ Pharmatest Services

◍ Urosphere

◍ MEDICILON

◍ Horizon Discovery

◍ Shanghai Model Organisms Center

◍ GemPharmatech

◍ LIDE Biotech

The Patient-derived Xenograft (PDX) market features players like Crown Bioscience and Champions Oncology, which utilize PDX models for drug efficacy testing and biomarker discovery. Companies like Wuxi Apptec and Charles River Laboratories enhance therapeutic developments, driving market growth. Sales revenues include:

- Crown Bioscience: $50M+

- Champions Oncology: $30M+

- Charles River Laboratories: $2.5B+

Request Sample Report

Market Segmentation

By Application

Preclinical Drug development

Biomarker Analysis

Request Sample Report

By Product

Mouse Model

Rat Model

Market Growth

Request Sample Report

$ X Billion USD

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
Global Patient-derived Xenograft (PDX) Models market cagr 12.8% by ReportPrime - Issuu